Visceral obesity and the heart
- PMID: 18201922
- DOI: 10.1016/j.biocel.2007.12.001
Visceral obesity and the heart
Abstract
Obesity and particularly its deleterious form, visceral adiposity, has reached a high prevalence in the industrialized world owing to the lack of exercise and the widely available energy-dense diet. As a consequence, cardiovascular diseases and metabolic disorders are afflicting an unprecedented number of individuals at a world-wide scale. Over the last decades, investigations have established firm links between visceral obesity and the development of cardiovascular diseases. Moreover, studies in the field of lipid partitioning have demonstrated that inadequacy of homeostatic mechanism ensuring adequate handling of energy surplus is associated with accumulation of visceral fat and lipid overload of internal organs, which are participating to the development of heart diseases. Visceral obesity and its metabolic consequences often referred to as the metabolic syndrome is associated with the production of an atherosclerosis prone milieu. In this review, clinical implications of visceral obesity on the development of cardiovascular disorders are reviewed along with important mechanisms participating to the development of these disorders. Implications and failure of lipid partitioning and some of the potential pathways mediating development of heart diseases are also covered in view of recent development of therapeutic options.
Similar articles
-
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343. Expert Rev Cardiovasc Ther. 2008. PMID: 18327995 Review.
-
Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.Obesity (Silver Spring). 2009 Mar;17(3):424-30. doi: 10.1038/oby.2008.555. Epub 2008 Dec 11. Obesity (Silver Spring). 2009. PMID: 19219061
-
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20. Arterioscler Thromb Vasc Biol. 2008. PMID: 18356555 Review.
-
Is visceral obesity the cause of the metabolic syndrome?Ann Med. 2006;38(1):52-63. doi: 10.1080/07853890500383895. Ann Med. 2006. PMID: 16448989 Review.
-
Metabolic implications of dietary trans-fatty acids.Obesity (Silver Spring). 2009 Jun;17(6):1200-7. doi: 10.1038/oby.2008.662. Epub 2009 Feb 19. Obesity (Silver Spring). 2009. PMID: 19584878
Cited by
-
11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases.J Clin Med. 2022 Oct 20;11(20):6190. doi: 10.3390/jcm11206190. J Clin Med. 2022. PMID: 36294507 Free PMC article. Review.
-
The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis.Br J Radiol. 2012 Jan;85(1009):1-10. doi: 10.1259/bjr/38447238. Epub 2011 Sep 21. Br J Radiol. 2012. PMID: 21937614 Free PMC article. Review.
-
Association between Abdominal Fat (DXA) and Its Subcomponents (CT Scan) before and after Weight Loss in Obese Postmenopausal Women: A MONET Study.J Obes. 2011;2011:239516. doi: 10.1155/2011/239516. Epub 2011 Mar 16. J Obes. 2011. PMID: 21603261 Free PMC article.
-
Stress urinary incontinence and visceral adipose index: a new risk parameter.Int Urol Nephrol. 2014 Dec;46(12):2297-300. doi: 10.1007/s11255-014-0832-9. Epub 2014 Sep 14. Int Urol Nephrol. 2014. PMID: 25218614
-
Effects Of Exercise Training With Dietary Restriction On Arterial Stiffness, Central Hemodynamic Parameters And Cardiac Autonomic Function In Obese Adolescents.Diabetes Metab Syndr Obes. 2019 Oct 17;12:2157-2163. doi: 10.2147/DMSO.S223514. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31802923 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
